Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Interest Expenses (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Interest Expenses for 4 consecutive years, with $3000.0 as the latest value for Q1 2023.

  • Quarterly Interest Expenses fell 85.71% to $3000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2023, down 85.71% year-over-year, with the annual reading at $4000.0 for FY2021, 75.0% down from the prior year.
  • Interest Expenses for Q1 2023 was $3000.0 at Relay Therapeutics, down from $21000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $21000.0 in Q1 2022, with the low at $3000.0 in Q2 2020.
  • Average Interest Expenses over 4 years is $7500.0, with a median of $5000.0 recorded in 2020.
  • The sharpest move saw Interest Expenses soared 320.0% in 2022, then tumbled 85.71% in 2023.
  • Over 4 years, Interest Expenses stood at $8000.0 in 2020, then crashed by 37.5% to $5000.0 in 2021, then skyrocketed by 320.0% to $21000.0 in 2022, then tumbled by 85.71% to $3000.0 in 2023.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $3000.0, $21000.0, and $5000.0 for Q1 2023, Q1 2022, and Q1 2021 respectively.